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Long-term neurological complications, termed sequelae, can result from viral
encephalitis, which are not well understood. In human survivors, alphavirus encephalitis
can cause severe neurobehavioral changes, in the most extreme cases, a
schizophrenic-like syndrome. In the present study, we aimed to adapt an animal model
of alphavirus infection survival to study the development of these long-term neurological
complications. Upon low-dose infection of wild-type C57B/6 mice, asymptomatic and
symptomatic groups were established and compared to mock-infected mice to measure
general health and baseline neurological function, including the acoustic startle response
and prepulse inhibition paradigm. Prepulse inhibition is a robust operational measure of
sensorimotor gating, a fundamental form of information processing. Deficits in prepulse
inhibition manifest as the inability to filter out extraneous sensory stimuli. Sensory gating
is disrupted in schizophrenia and other mental disorders, as well as neurodegenerative
diseases. Symptomatic mice developed deficits in prepulse inhibition that lasted through
6 months post infection; these deficits were absent in asymptomatic or mock-infected
groups. Accompanying prepulse inhibition deficits, symptomatic animals exhibited
thalamus damage as visualized with H&E staining, as well as increased GFAP expression
in the posterior complex of the thalamus and dentate gyrus of the hippocampus. These
histological changes and increased GFAP expression were absent in the asymptomatic
and mock-infected animals, indicating that glial scarring could have contributed to
the prepulse inhibition phenotype observed in the symptomatic animals. This model
provides a tool to test mechanisms of and treatments for the neurological sequelae of
viral encephalitis and begins to delineate potential explanations for the development of
such sequelae post infection.
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INTRODUCTION
Neurological sequelae are a widespread and understudied consequence of virus encephalitis that
can have profound influence on the survivor’s quality of life. Neurological sequelae are those
complications involving damage to the central nervous system that results in cognitive, sensory, or
motor deficits that may also manifest as emotional instability and even seizures, in the most severe
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cases. Sequelae affect persons in all age groups and levels of
immunocompetence. Neurological complications resulting from
viral infections have recently become the focus of much media
attention. For example, Zika infection is apparently associated
with developmental microcephaly and Guillain-Barré syndrome
(Wu et al., 2016), Chikungunya infection with arthritis (Rampal
et al., 2007; Bhavana et al., 2008; Chusri et al., 2011), Ebola virus
infection with sensory impairment and behavioral changes, and
Lassa virus infection with hearing loss (Cummins et al., 1990;
Okokhere et al., 2009; Ibekwe et al., 2011).
Venezuelan equine encephalitis virus (VEEV), eastern equine
encephalitis virus (EEEV), and western equine encephalitis virus
(WEEV) are the three most common encephalitic alphaviruses
associated with neurological sequelae in the Americas (Mulder
et al., 1951; Finley and Chapman, 1953; Fulton and Burton,
1953; Palmer and Finley, 1956; Hanson, 1957; Herzon et al.,
1957; Cohn and Kuida, 1962; Earnest et al., 1971; Bowen et al.,
1976; White et al., 1983; Deaton et al., 1986; Carrera et al.,
2013; Silverman et al., 2013). Sequelae of alphavirus infection
include seizures, photophobia, intellectual disability, emotional
instability, behavioral changes, neuromuscular weakness, and
paralysis and the incidence of these symptoms can occur in up
to 75% of surviving patients (Mulder et al., 1951; Finley and
Chapman, 1953; Fulton and Burton, 1953; Palmer and Finley,
1956; Hanson, 1957; Herzon et al., 1957; Cohn and Kuida, 1962;
Earnest et al., 1971; Bowen et al., 1976; White et al., 1983;
Deaton et al., 1986; Carrera et al., 2013; Silverman et al., 2013).
When evaluating extreme outcomes, one unfortunate patient was
misdiagnosed and treated for schizophrenia after recovering from
an undetected WEEV infection. Eighteen months passed before
doctors were able to correctly link the patient’s symptoms as
neurological sequelae of encephalitis (Deaton et al., 1986). This
is not the only example of severe behavioral symptoms following
viral encephalitis. Studies in two Canadian psychiatric hospitals
observed that 32 patients had antibodies against WEEV or a
related encephalitic virus (Fulton and Burton, 1953), leading the
authors to suggest that viral infection may have contributed to the
patients neurological disease.
The economic burden resulting from alphavirus (EEEV)
neurological sequelae can exceed $3 million per patient per year
(1995 dollars) (17). This estimate did not include the costs of
initial hospitalization, estimated to be $21,000 per patient per
week, nor the cost of institutionalization for patients that do not
have family members to aid in long-term convalescence (Villari
et al., 1995). Thus, relevant animal models with appropriate face
validity for the neurological sequelae resulting from alphavirus
encephalitis are crucial for accurate diagnosis and effective
treatments; not to mention enhanced quality of life and relief
from the economic burden associated with surviving these
infections.
We initiated validation of a mouse model for VEEV
neurological sequelae by infecting C56BL/6 with TC-83, an
attenuated VEEV strain (McKinney et al., 1963). By using TC-
83, we were able to adapt biosafety level (BSL)-1 neurobehavioral
techniques in a BSL-2 setting. This is valuable, as studies will need
to be translated to BSL-3 to study the wild-type strains of VEEV
and the other encephalitic alphaviruses. We evaluated baseline
neurological function in mice using the SHIRPA, acoustic startle
reflex (ASR), and prepulse inhibition paradigm (PPI). SHIRPA
is a semi-quantitative neurological assessment of general health,
neurological reflexes, and baseline behavior (Rogers et al., 1997,
2001). ASR evaluates an animal’s ability to perceive and respond
to acoustic startle stimuli while PPI assesses sensorimotor gating
of the ASR stimuli (Koch, 1999); thus, allowing the evaluation
of a multi-synaptic reflexive brain circuit in hearing-competent
animals (Koch and Schnitzler, 1997; Koch, 1999; Fendt et al.,
2001; Crawley, 2007). Deficits in PPI is related to a variety of
psychobehavioral diseases, such as schizophrenia (Braff et al.,
1978, 2001a,b; Davis et al., 1982; Grillon et al., 1992; Koch,
1999), attention deficit disorder/attention deficit hyperactivity
disorder (Castellanos et al., 1996; Kohl et al., 2013), anxiety
(Ludewig S. et al., 2002; Kohl et al., 2013), depression (Kohl
et al., 2013), and Alzheimer’s disease (Salem et al., 2011; Wang
et al., 2012; Koppel et al., 2014). Rodent animal models for
ASR and PPI deficits have been developed and successfully
used to model the sensorimotor gating deficits of these diseases.
However, neurobehavioral testing has yet to be used to evaluate
neurological sequelae due to arboviral infection in mice (Fendt
and Koch, 1999; Schauz and Koch, 1999; Swerdlow et al.,
1999, 2001; Geyer et al., 2001, 2002). In addition to these
neurobehavioral tests, we will use histological staining of brain
cell populations to evaluate neurodegeneration using NeuN as
a marker, an antibody specific to mature neurons. Activation of
astrocytes can lead to neuroinflammation and cell damage. This
will be evaluated using glial fibrillary acidic protein (GFAP) as
a marker. Evaluating astrocyte activation and neurodegeneration
of animals with different symptom presentations provides initial
insight into mechanisms of damage. Thus, we describe a
novel approach to study neurological sequelae resulting from
alphavirus encephalitis
MATERIALS AND METHODS
Cells, Viruses, and Biosafety
Vero cells (American Tissue Culture Collection CRL-1586)
were maintained in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal calf serum, 1% penicillin-
streptomycin, and L-glutamine. Viral working stocks were
produced in Vero cells. All work with infectious virus was
performed at UTMB BSL-2 or 3 in accordance with institutional
health and safety guidelines.
Animal Experiments
Six to eight-week-old female wild-type C56BL/6 were purchased
from Jackson Laboratories (Bar Harbor, ME, USA). All animals
were housed in a pathogen-free environment. All virus infections
were performed in the ABSL2 or ABSL3 facility in the Galveston
National Laboratory (GNL), UTMB. All animal studies were
reviewed and approved by the Institutional Animal Care and
Use Committee at UTMB and were carried out in accordance
with the National Institute of Health guidelines. Animals
were anesthetized using an isoflurane precisions variable-
bypass vaporizer prior to intranasal virus inoculation with
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103 PFU TC-83 diluted in PBS (N = 10, performed as two
separate experiments of N = 5) or PBS as a mock infection
(N = 4). Standardized recording of death and disease symptoms
was performed using the following definitions: encephalitis,
ruﬄed fur, hunched back, reduced activity, development of
discoordination, ataxia, or transient seizures (with the ability
to drink and feed); paralysis; and hind limb (hemiplegic) or
quadriplegic paralysis (with the inability to reach the feeder
or water bottle). Body weight was measured throughout the
course of study. Seroconversion was determined by plaque
reduction neutralization test (PRNT) at 6 months post infection
(m.p.i.).
General Health Assessment
A modified SHIRPA screen was used to analyze the general
health of each animal pre- and post-infection. Semi-quantitative
measures were performed to evaluate body tone, trunk
curl, righting, reach touch, whisker response, ear twitch,
palpebral reflex, forelimb place, and grip time. Semi-quantitative
measurements were ranked on a sale of 0 to 3, with 0 being
the lowest possible, 1 equating to less than normal, 2 equating
to normal, and 3 equating to hyperactive (Table 1). The body
tone test was done by using two fingers to depress along the
spine of the animal and record the animal’s response. Trunk
curl was done by holding the animal by the base of the tail
above the ground and observing the angle measured vertically
against a sheet of marked paper to which the animal curls.
A normal animal should be able to curl to at least 90◦. The
righting reflex was determined by flipping the animal on its
back in the palm of a hand and evaluating its ability to
bring itself back on all four paws. Reach touch was evaluated
by holding the animal from the base of the tail above a
surface and slowly lowering it towards the ground. A normal
animal will reach its front paws towards the surface as it is
lowered, indicating intact vision. The whisker response and ear
twitch tests were performed by lightly flicking the whisker or
ear with an elongated Q-tip from behind and observing the
animal’s response. The palpebral reflex test was done by slowing
approaching the eye with a cotton-tipped swab and observing
when/if the animal responds by blinking. The forelimb place
was done with the animal sitting with all four paws on a flat
surface. Each paw was moved to the side using forceps and
the animal’s response was observed. It is expected that the
animal will return its forelimb close to its original position
and it is abnormal for the animal not to fix the placement
of its paw. Grip time was determined by placing an animal
on a wire cage top and turning the cage top upside down.
Normal animals should be able to hold on to the cage for
at least 60 s, so this test was concluded once the animal’s
grip time exceeded 60 s. The above described tests were done
as previously described (Rogers et al., 1997; Crawley, 2007).
The response to each was rated on a scale of 0 to 3, with
0 indicating no response, 1 indicating a less than normal
response, 2 indicating a normal response, and 3 indicating an
exaggerated response. We established baseline SHIRPA 1 week
prior to infection. Post-infection measurements were evaluated
beginning 1 month post infection through the end of the study at
6 m.p.i.
Acoustic Startle Reflex (ASR) and
Prepulse Inhibition (PPI)
Acoustic Startle Reflex (ASR) was used to measure reactions
to startle-eliciting sounds pre- and post-TC-83 infection in
WT C56BL/6 mice. Baseline ASR was established 1 week
prior to infection and 1, 3, and 6 m.p.i. Each animal was
placed in a tube restraint large enough for the animal to
turn around in then placed in the SR-Lab startle response
system sound attenuating cabinet (San Diego Instruments).
The SR-Lab startle response system recorded the amplitude of
each animal’s movement in response to acoustic startle stimuli
across a 100 ms window following stimulus onset. Experimental
parameters and stimuli presentations were controlled with SR-
Lab software. Prior to the onset of the experiment, each
animal was subjected to a 3–5-min acclimation period in
the cabinet. A startle stimulus of 120 d B was presented
as 20 ms bursts in the presence of a 65 dB background
noise. The control stimulus consisted of 20 ms presentations
of the 65 dB background noise. The acoustic stimuli were
presented in a randomized order with a total of 10 trials for
each option. The inter-trial interval varied between 10 and
20 s. The amplitude of the animal’s movement was measured
in mV.
Prepulse inhibition paradigm (PPI) was evaluated 1 week
pre-infection and 1, 3, and 6 m.p.i. for all animals. Animals
TABLE 1 | SHIRPA scoring.
0 1 2 (Normal) 3
Body tone (muscular, agitation) Flaccid, no reaction Depression to floor Slight resistance to touch Hunches back to resist
depression, irritable
Trunk curl (muscular) No response or hindlimb
clasping
Curls < 90◦ Curls ≥ 90◦ Climbs up tail
Righting (muscular) Does not right Struggles to right Rights itself Hyperactive response
Forelimb place (muscular) Leg stays where placed Slow or incomplete return to
position
Promptly returns to position Hyperactive response,
does not allow adjustment
Palpebral Reflex (visual) No response Slow blink Quick blink Continues blinking upon
removal of stimulus
Reach touch (visual) Does not reach, clasps
hindlimbs
Does not reach until whiskers
touch surface
Reaches as approach ground
before whiskers touch surface
Hyperactive, tail climbing
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were acclimated to the chamber as described above for
ASR. Within 100 ms prior to the 120 dB startle stimulus,
prepulses at 6, 12, and 18 dB above the 65 dB background
were presented. No prepulse prior to the 120 dB startle
served as baseline. Prepulse stimuli were presented in a
randomized order with a total of 10 trials for each option.
The inter-trial interval varied between 10 and 20 s. The
amplitude of the animals’ movement was measured at each
prepulse level and the percent inhibition was calculated using
the following equation: 100[(Startle Amplitude – PPI Startle
Amplitutde)/Startle Amplitude].
Brain Histology
At the conclusion of the study (6 m.p.i), mice were killed with
carbon dioxide. Whole brains (Mock N = 4, Asymptomatic
N = 7, Symptomatic N = 3) were removed, fixed in
10% buffered formalin (Sigma–Aldrich, HT501128-4L), then
embedded in paraffin by the University of Texas Medical
Branch Histology Core (directed by Dr. Marjan Afrouzian).
Five micrometer sagittal slices were cut on a Leica RM2125
microtome then stained with hematoxylin and eosin or with
primary and secondary antibodies for immunofluorescence
microscopy. Primary antibodies employed were: NeuN (Cell
Signaling D3S3I Rabbit mAB, 1:500), and GFAP (Aves Labs,
Inc. Chicken mAB Catalog#GFAP, 1:2000). Secondary antibodies
used were: goat anti-rabbit IgG (DyLight 488ThermoFisher
Catalog#35552, 1:250) and goat anti-chicken IgY (DyLight
594 ThermoFisher Catalog#SA5-100072, 1:250). Sections were
coverslipped with DAPI-containing mounting media (DAPI
Fluoromount-G, SouthernBioTech). GFAP-positive cells were
quantified by counting the number of GFAP-positive cells
in the 20x field of view centered either on the posterior
complex of the thalamus (PO) or dentate gyrus (DG), then
counting the number of NeuN-positive cells in that field. The
field of view for each animal was determined and replicated
using a brain atlas (Paxinos and Franklin, 2004) such that
comparisons between animals occurred using three slices, each
corresponding to 0.6–0.85 mm lateral sections as determined
through the use of the atlas. The ratio of GFAP:NeuN
positive cells were determined for three consecutive slices
for animals from each group, again with the slices falling
within 0.6–0.85 mm lateral sections. DAPI-staining was used
to normalize the total number of cells within a field of
view.
Statistical Analyses
Each group’s weight (symptomatic, asymptomatic, and mock)
was compared using one-way ANOVA. A within group paired
t-test was used to compare baseline ASR amplitudes and percent
inhibition in the PPI test to post-infection values, according to
previously published studies (Yee et al., 2005). A p-value of less
than 0.05 was considered statistically significant for all tests.
The ratios of GFAP:NeuN-positive cells were compared between
each group (mock, asymptomatic, symptomatic) using one-way
ANOVA.
RESULTS
General Health Assessment
WT C56BL/6 mice were infected with 103 PFU TC-83 (N = 10)
or mock infected with an equal volume of PBS (N = 4).
Infected animals were divided into symptomatic (N = 3) and
asymptomatic (N = 7) animals based on the development
of weight loss and disease symptoms. Symptomatic animals
displayed disease symptoms of ruﬄed fur, hunched back, and
reduced activity recorded within 14 d.p.i, while asymptomatic
animals did not display these disease characteristics and
maintained an overall healthy appearance post-infection within
14 d.p.i. All symptomatic animals developed weight loss
consistent with disease by 5 d.p.i. and recovered weight by 11
d.p.i (Figure 1). However, these symptomatic mice had lower
body weights at the time of infection than their asymptomatic
cage mates. By 2 d.p.i., all animals had comparable weights.
We are unable to determine if this affected the development
of disease symptoms. As expected, no animals succumbed to
challenge. Seroconversion, as measured by PRNT (data not
shown), occurred in all symptomatic animals and 2 out of
7 asymptomatic animals. Asymptomatic animals that did not
seroconvert were still considered infected due to the low dose
infection used and the poor immunogenicity established for
TC83 (Pittman et al., 1996).
All animals were evaluated for behavioral changes until 6
m.p.i., when the study was terminated. The SHIRPA (Rogers
et al., 2001) general health and neurological screen was used to
reveal discrete neuromuscular phenotypes in infected animals
(Table 2). Baselines were established for each animal 1 week prior
to infection and then were evaluated weekly beginning 1 m.p.i.
until 6 m.p.i. Abnormalities were identified in righting reflex, grip
latency, forelimb place, body tone, and trunk curl for infected
animals but not animals in the mock group (Table 2). The
only animals that sustained abnormalities in grip time, righting,
and forelimb place from 1 m.p.i. to 6 m.p.i were those that
displayed symptoms post-infection, as described above. However,
both symptomatic and asymptomatic animals presented with
abnormalities in body tone and trunk curl from 1 m.p.i. to
6.m.p.i. It is important to note that not all animals exhibited the
same directionality of altered response to trunk curl and body
tone; with 6 showing an attenuated response and 4 showing an
exaggerated response.
Acoustic Startle and Prepulse Inhibition
To determine the sensorimotor gating deficits associated with
PPI, the baseline startle response and was established and we
confirmed functional hearing prior to PPI evaluation (Figure 2).
The startle response was statistically unchanged in any group
when compared to its pre-infection baselines (Figure 2A).
The startle response is expected to decrease slightly over time
due to habituation to the procedure, and as expected, appears
to decrease but was not a significant decrease (Figure 2A).
However, a decrease in percent inhibition at three different
prepulse intensities (+6, 12, and 18 dB above background) was
statistically significant for animals in the symptomatic group
at 1 m.p.i. (p = 0.04, p = 0.05, p = 0.05) that continued
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FIGURE 1 | Six-to-eight-week-old wild-type C57BL/6 mice infected with TC-83 or mock infected with PBS were monitored throughout the course of
study. Symptomatic (S, N = 3) animals developed weight loss consistent with infection around D5 and did not begin regaining weight until D11. Asymptomatic (A,
N = 7) and mock (M, N = 4) animals did not develop weight loss or show other signs of infection. S animals did not reach weights comparable to the A or M animals
until D20. Weights are expressed with grams with the SD for each group. Asterisks indicate significantly lower weights (p < 0.05) in the symptomatic groups when
compared to both asymptomatic and mock groups. When compared using a One-Way ANOVA, weights were not significantly different between mock or
asymptomatic groups post-infection.
to be significant through 6 m.p.i. (p = 0.0001, p = 0.002,
p = 0.002) (Figures 2B–D) when compared to baseline pre-
infection measurements. This decrease was not detected in mock
or asymptomatic animals at any of the prepulse intensities
(Figures 2B–D). Thus, while asymptomatic mice exhibited
muscle weakness and gait abnormalities as measured by SHIRPA,
only symptomatic mice displayed CNS circuit abnormalities as
measured by PPI.
Histopathological Changes
Next, brains of symptomatic, asymptomatic, and mock-infected
animals were compared. At the conclusion of the study (6 m.p.i),
whole brains were collected from the animals and fixed in 10%
buffered formalin. Five um sagittal brain slices were stained with
hematoxylin and eosin to resolve general brain structure and
potential damage. Symptomatic animals displayed damage to the
thalamus, as indicated by enhanced hematoxylin deposition, with
one animal displaying glial nodules and damage possibly due to
calcification (Figure 3). Interestingly, this damage was not seen
in mock or asymptomatic animals (Figure 3).
Slices were next probed for NeuN to detect mature neurons,
GFAP to detect activated astrocytes/microglia, and DAPI to
identify cell nuclei. The ratio of GFAP-positive to NeuN-positive
cells was determined for each field of view. Symptomatic,
asymptomatic, and mock animals were compared by the ratio of
GFAP:NeuN for at least 3 consecutive slices from each animal
in comparable regions of the brain (i.e., thalamus, dentate
gyrus, and superior and inferior colliculi). Increased GFAP:NeuN
ratios were detected in symptomatic animals when compared
to mock in the dentate gyrus (DG) (p = 0.0014) and posterior
complex of the thalamus (PO) (p= 0.0049) (Figure 4). Although
there seemed to be a trend of increased GFAP expression in
asymptomatic animals compared to mock animals, this was not
statistically significant in the DG or PO (Figure 4). There was
no significant change in GFAP:NeuN ratios in the superior or
inferior colliculi (data not shown).
DISCUSSION
This study describes the initial validation of a mouse model
for neurological complications that can occur post-alphavirus
infection. Validation of an animal model requires that the
model have face validity, construct validity, and predictive
validity. Face validity requires that the model mimic human
symptoms, construct validity that the model replicate structural
and neurochemical defects, and predictive validity ensures that
the model reflects responses to treatment that are described in
human use (Chadman et al., 2009; Jones et al., 2011). At this stage,
this model meets the criteria described for face validity and the
overt structural defects supports construct validity.
In this model, low-dose infection with TC-83 led to the
development of encephalitis and survival for long-term study.
For the first time, the detectable changes in general health,
neurological reflexes, sensory function, and sensorimotor gating
were observed and quantified in the context of alphavirus
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FIGURE 2 | (A) The startle response is unaffected pre- and post-infection in mock, asymptomatic, and symptomatic groups. A slight statistically insignificant
decrease over time is expected due to long-term habituation to the testing. At 6dB (B), 12dB (C), or 18dB (D) above background noise, all groups can reach up to
60% inhibition of the startle response. At 1 m.p.i and 6 m.p.i, this percent inhibition is significantly decreased in symptomatic animals, but not in mock or
asymptomatic animals. Baseline and post-infection time points were compared using a paired t-test.
infection (Figures 1 and 2; Table 2). It was anticipated that
the low-dose of infection would not lead to detectable infection
in all animals, thus providing a way to evaluate sequelae of
symptomatic and asymptomatic infections. All symptomatic
animals seroconverted by the end of the study (6 m.p.i.), while
only 2 of the 7 asymptomatic animals showed evidence of
seroconversion at that time. Thus, these findings support the face
validity of this model to mimic human alphavirus infection, as
these infections can range from asymptomatic to encephalitis.
Infected animals had abnormalities in neuromuscular tests,
which indicate that there may be damage to nerves that relate
to the control of voluntary and reflex muscle movement. This is
consistent with what is described in human disease and further
supports the face validity of this model. All animals infected with
TC-83 displayed abnormalities in their body tone and trunk curl.
The body tone test, sometimes called touch escape, evaluates
the animal’s physical response upon slight depression along the
spine towards the head. Infected mice were irritable upon touch
(N = 4), while others allowed depression to the floor and did not
react to the physical pressure (N = 6). The trunk curl test also
evaluates the mouse’s neuromuscular abilities by evaluating the
approximate angle that the mouse can pull itself up when held
by the base of the tail (Crawley, 2007). Only some symptomatic
animals had abnormalities in grip time (less than 60 s) (N = 2),
forelimb place (N = 1), and righting (N = 1) lasting through
6 m.pi. Abnormalities in these general reactivity tests could
indicate a physical or muscle problem in animals with less than
normal responses, potentially due to the descending projections
of the motor tracts in the somatic or autonomic nervous systems.
Alternatively, an exaggerated response could indicate irritability.
In fact, the exaggerated response to body tone assessment has
been indicated as a model for non-cognitive symptoms associated
with dementia (Reisberg et al., 1987). This exaggerated response
and associated irritability are interesting because case reports of
alphavirus infections have described dementia as one possible
sequelae, and the sequelae of alphaviruses are not all related to
cognition. At this stage, the neuromuscular deficits detected in
this model correlate with those that are described in alphavirus
encephalitis survivors, as well as individuals infected with West
Nile Virus (Mulder et al., 1951; Bruyn and Lennette, 1953; Palmer
and Finley, 1956; Herzon et al., 1957; Earnest et al., 1971; Leon,
1975; Bowen et al., 1976; Patel et al., 2015).
Infection did not alter the basic startle response amplitude
over the 6 months of observation, but symptomatic infection
led to deficits in PPI (Figure 2). To understand what was
observed in this study, one must understand the ASR and PPI
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FIGURE 3 | Panels 1–3 are symptomatic animals (4x magnification lens), panel 4–6 represents zoom-in panels of the boxed damage of panels 1 and 2
(10× magnification lens), panel 7 represents a mock animal (4× magnification lens), and panels 8–9 represent asymptomatic animals (4×
magnification lens). All symptomatic animals had visible damage to the thalamus, such as the glial nodules (panels 1 and 2, higher magnification in panels 4 and 6)
and calcification (panel 2, higher magnification in panel 5. This same damage is not seen in mock (panel 7) or asymptomatic (panels 8–9) animals.
pathways. Upon presentation of a startle stimulus, the soundwave
travels through the cochlea to activate the appropriate hair cells
that communicate acoustic information to the caudal pontine
reticular nucleus, sending the signal for the motor response to
the motor neurons (Fendt et al., 2001). When a prepulse is
presented at the appropriate interval prior to the startle stimulus,
the prepulse is processed via the default pathway, rerouting
the startle stimulus through the inferior and superior colliculi
from the cochlear nuclei, then to the pedunculopontine reticular
nucleus before being re-routed to the caudal pontine reticular
nucleus and motor neurons of the traditional acoustic pathway
(Fendt et al., 2001). From the caudal pontine reticular nucleus,
the signal for the motor reflex is sent through the spinal cord
to elicit a motor response. This is done by transferring a signal
to the spinal interneurons, which are responsible for creating the
neural circuits that relay information between sensory and motor
neurons, which then relay the signal to spinal motor neurons for
the physical response (Yeomans and Frankland, 1995). There are
many aspects of the startle response to evaluate to determine the
cause of deficits in sensorimotor gating and the motor response.
The observation that the startle response was unaltered over the
course of the study, but the alterations in percent inhibition
of symptomatic animals indicates impairment in sensorimotor
gating, a reflexive process that blocks redundant stimuli and
prevents an overload of information. This impairment is a
phenotype associated with neurological disorders, including but
not limited to schizophrenia, ADD/ADHD, Alzheimer’s, and
Autism spectrum disorders (Grillon et al., 1992; Kumari et al.,
1999; Braff et al., 2001b; Ludewig K. et al., 2002). Overall,
the results observed regarding ASR and PPI measurements
correlate with the kinds of sequelae expected from human
cases.
The pathological lesions observed are relevant to the outcomes
measured by the SHIRPA examination, ASR, and PPI. In this
study, mice with PPI deficits exhibited damage in the thalamus,
but not to other areas of the brain (Figure 4). The thalamus is
situated between the cortex and the midbrain, acting as a relay
between different subcortical areas and the cortex. Thus, it is
involved in sensory perception, regulation of motor functions,
regulation of reflexes from auditory and visual stimuli, and
consciousness. The thalamus has been noted as a region of
importance for neurological diseases including schizophrenia,
depression, anxiety, Parkinson’s disease, and epilepsy. Rodent
models of schizophrenia provide valuable information regarding
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FIGURE 4 | Symptomatic animals had more GFAP expression than both asymptomatic and mock groups in the dentate gyrus (DG) and posterior
complex of the thalamus (PO). Asymptomatic animals had more GFAP expression than the mock animals, but less so than symptomatic animals. GFAP
expression was determined by dividing counts of GFAP positive cells by NeuN positive cells in comparable fields of view. Representative images from each group are
depicted. Green: NeuN, Red: GFAP, Blue: DAPI. ns: not significant, ∗p < 0.005. S: symptomatic; M: mock; A: asymptomatic.
changes in PPI, but this information can be applied to other
neurological disorders. For example, disruption of the thalamic
inputs have been described to play a role in sensorimotor gating
deficits (Chun et al., 2014). Additionally, Klein and colleagues
observed that deep brain stimulation of the dorsomedial
thalamus normalized PPI deficits in two rat models (Klein et al.,
2013) and Alsene and colleagues determined that infusion of
norepinephrine into the dorsomedial thalamus disrupted PPI in
mice (Alsene et al., 2011). Information regarding the functions
of the thalamus and its role in rodent models of neurological
disease resulting in disrupted PPI supports the structural basis
for construct validity of the neurological disorders in the mouse
model described here.
To further evaluate the construct validity of the structural
damage in the context of virus infection, previous histopathology
reports of encephalitic alphavirus infection in horses
(Monlux and Luedke, 1973; Monath et al., 1981; Del Piero
et al., 2001; Silva et al., 2011), guinea pigs (Roy et al.,
2009), deer (Kiupel et al., 2013), and nonhuman primates
(Nathanson et al., 1969) were examined. These reports
identified virus in the thalamus and thalamic damage as
a result of infection similar to what is described in this
study. In fact, virus has been detected in the thalamus of
lethal human cases (Nathanson et al., 1969; Luby et al.,
1971). However, due to the lethality of the virus, these
previous reports were only able to evaluate the results of
TABLE 2 | General health changes pre- and post- infection.
Body Tone Trunk Curl Righting Forelimb place Grip Time
Pre-infection (1 week)
Infected
Mock
Normal/Abnormal
10/0
4/0
Normal/Abnormal
10/0
4/0
Normal/Abnormal
10/0
4/0
Normal/Abnormal
10/0
4/0
Normal/Abnormal
10/0
4/0
Post-infection (1 month)
Infected
Mock
Normal/Abnormal
0/10
4/0
Normal/Abnormal
0/10
4/0
Normal/Abnormal
9/1
4/0
Normal/Abnormal
8/2
4/0
Normal/Abnormal
8/2
4/0
Post-infection (6 month)
Infected
Mock
Normal/Abnormal
0/10
4/0
Normal/Abnormal
0/10
4/0
Normal/Abnormal
9/1
4/0
Normal/Abnormal
9/1
4/0
Normal/Abnormal
8/2
4/0
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acute infection leading to death and did not look at the long-
term effects of infection in this region and in the host, such as
PPI, ASR, and other behavioral outcomes. Further investigations
are required to delineate the role of thalamus damage to these
complications of infection and evaluate the predictive validity of
the model using methods to stimulate the thalamus and reverse
PPI deficits.
Additional phenotypic measures to provide construct validity
were evaluated. This was accomplished through GFAP and NeuN
staining. GFAP is an intermediate filament protein expressed by
astrocytes in the CNS. It’s direct role in neurological diseases is
not well understood and somewhat controversial depending on
the disease in question, but increased GFAP staining is associated
with gliosis and neuroinflammation (Jeglinski et al., 1995; Arnold
et al., 1996; Iliev et al., 2001; Sawaguchi et al., 2003; Catts et al.,
2014; Niranjan et al., 2014). Alphaviruses have been described to
infect astrocytes and the affect is cytotoxic (Schoneboom et al.,
1999). This cytotoxicity in conjunction with infection of other
CNS cell types leads to neuroinflammation (Schoneboom et al.,
2000). NeuN is a neuronal nuclear antigen that stains for mature
neurons. Evidence for increased GFAP, potentially indicating
gliosis and neuroinflammation, was observed in the dentate gyrus
and posterior complex of the thalamus of symptomatic mice, but
not asymptomatic or control mice (Figure 4). The observation
of increased GFAP only in the dentate gyrus, a region of the
hippocampus important to memory, and posterior complex of
the thalamus indicates potential alphavirus susceptibility in those
regions. Alternatively, no change in the expression of NeuN was
detected (Figure 4), indicating that there was no significant loss
or gain of neurons as a result of this infection. These data indicate
that astrocytes and their secreted cytokines may play a larger
role in the development of sequelae than neurons, but additional
studies will be required to delineate these roles.
CONCLUSION
This study led to the initial development of an infection-based
murine model that develops multiple neurological complications
documented in human alphavirus infection. We acknowledge
that our small sample size is a limitation of this study.
To further support our results and strengthen the face and
construct validities of the model described above, additional
studies with larger sample sizes will be required. In addition
to demonstrating reproducibility of the model, specifically
evaluating the neurochemical defects, resulting gene and protein
expression, as well as the effects of therapeutic interventions on
outcomes in infected animals will allow us and others to delineate
mechanisms associated with the long-term neurological sequelae
of alphavirus encephalitis. This combination of neuroscience and
infectious disease will be crucial to improving the quality of life
for survivors of these infections and help adapt these techniques
for the study of other viral encephalitis sequelae, such as Zika
virus or Ebola virus, and learn how viral infections can lead to
or exacerbate neurological disorders.
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